609 articles
A phase I trial tests SD-101, nivolumab, and radiation together against metastatic pancreatic cancer that has stopped responding to chemo.
A 260-infant RCT tests whether adding bleomycin injections to low-dose propranolol accelerates hemangioma regression and improves skin outcomes.
Researchers at Assiut University investigated whether COVID-19 infection triggers serious blood disorders including aplastic anemia and immune cytopenias.
A Phase 1/2 trial tests a custom cancer vaccine paired with checkpoint inhibitors in patients with advanced solid tumors.
A completed University of São Paulo trial explored whether taurine supplementation can reduce oxidative stress — a key driver of aging.
A Phase 1 trial tests whether lowering compensatory hyperinsulinemia with diazoxide improves glucose and lipid metabolism in NAFLD patients.
Completed French trial uses advanced brain imaging to track 5-HT4 serotonin receptors in Parkinson's patients, linking genetics to cognitive and mood changes.
A University of Florida trial tests whether one night without sleep harms vascular function — and if exercise training can protect against it.
A multicenter trial tests whether 12 weeks of resistance training can improve frailty, muscle power, and quality of life in centenarians.
A Phase 2 trial explores whether cilostazol, a blood thinner with brain-protective effects, can slow memory loss in MCI patients.
A completed phase 3 trial compared A+AVD versus ABVD for advanced classical Hodgkin lymphoma, testing whether replacing bleomycin with brentuximab vedotin improves outcomes.
A Phase 2 trial tests whether selatogrel, a subcutaneous P2Y12 inhibitor, can rapidly block platelet aggregation in stable coronary artery disease patients.
